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Abstract
Background: Acute or chronic tissue damage induces an inflammatory response accompanied by pain and
alterations in local tissue temperature. Recent studies revealed that the transient receptor potential A1 (TRPA1)
channel is activated by a wide variety of substances that are released following tissue damage to evoke
nociception and neurogenic inflammation. Although the effects of a noxious range of cold temperatures on TRPA1
have been rigorously studied, it is not known how agonist-induced activation of TRPA1 is regulated by
temperature over an innocuous range centred on the normal skin surface temperature. This study investigated the
effect of temperature on agonist-induced currents in human embryonic kidney (HEK) 293 cells transfected with rat
or human TRPA1 and in rat sensory neurons.
Results: Agonist-induced TRPA1 currents in HEK293 cells were strongly suppressed by warm temperatures, and
almost abolished at 39°C. Such inhibition occurred when TRPA1 was activated by either electrophilic or non-
electrophilic agonists. Warming not only decreased the apparent affinity of TRPA1 for mustard oil (MO), but also
greatly enhanced the desensitization and tachyphylaxis of TRPA1. Warming also attenuated MO-induced ionic
currents in sensory neurons. These results suggest that the extent of agonist-induced activity of TRPA1 may
depend on surrounding tissue temperature, and local hyperthermia during acute inflammation could be an
endogenous negative regulatory mechanism to attenuate persistent pain at the site of injury.
Conclusion: These results indicate that warmth suppresses and desensitizes damage-sensing ion channel TRPA1.
Such warmth-induced suppression of TRPA1 may also explain, at least in part, the mechanistic basis of heat
therapy that has been widely used as a supplemental anti-nociceptive approach.
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Background
Transient receptor potential A1 (TRPA1) is a Ca
2
+-permeable non-selective cationic channel enriched in
a subpopulation of nociceptive sensory neurons [1,2].
The activation of TRPA1 directly evokes pain and
induces vasodilation and neurogenic inflammation.
TRPA1 can be activated by a wide range of irritants
including mustard oil (MO), cinnamaldehyde, and for-
maldehyde. Endogenous products generated by tissue
damage and oxidative stress, such as H2O2,4 - h y d r o x y -
nonenal, prostaglandin J2, and reactive oxygen and
nitrogen species can also activate TRPA1 [3]. Thus,
TRPA1 functions as a sensor of endogenous tissue
damage and exogenous harmful compounds, and is
implicated in multiple pathological conditions, including
chronic pain and respiratory and cardiovascular diseases
[3-5]. Recently, a gain-of-function mutation of TRPA1
N855S was found to cause familial episodic pain syn-
drome [6], further suggesting a role for TRPA1 in
nociception.
Many agonists activate TRPA1 by covalent binding to
reactive residues located at an intracellular amino term-
inal domain [7,8]. Since the covalent modification of
TRPA1 by an electrophilic agonist is not readily reversi-
ble after washout, but persists for more than an hour
[8], TRPA1 activation by reactive agonists typically show
prolonged residual activity even following washout [7-9].
Thus TRPA1 may be persistently activated by endogen-
ous agonists that are released at the site of injury or
inflammation [10-14]. Consistent with this notion,
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pain under various pathological conditions in experi-
mental animals [15-18]. Therefore, developing a more
effective approach to suppress the activity of TRPA1
may be beneficial in the treatment of chronic pain
conditions.
Since mammalian TRPA1 was originally proposed as a
noxious cold sensor [2], the activation of TRPA1 has
been rigorously studied over a cold temperature range.
Although cold sensitivity of TRPA1 is controversial [19],
a recent study reported a potentiating effect of cold on
agonist-induced activation of TRPA1, suggesting it has a
role in cold hyperalgesia rather than cold pain [20].
However, it is not known how the agonist-induced acti-
vation of TRPA1 is affected by temperature changes at
the skin surface. Moreover, acute or chronic inflamma-
tory conditions in human and experimental animals are
accompanied by alterations in the local tissue tempera-
ture [21-24]. Therefore, investigating the effects of tem-
perature at the skin surface on agonist-induced
activation of TRPA1 should provide information about
TRPA1 activity under conditions that are more patho-
physiologically relevant.
In this study, we assessed the effect of the temperature
on agonist-induced activation of TRPA1 in vitro.
Results
Agonist activation of TRPA1 is strongly suppressed by
warmth
To investigate the modulation of agonist-induced activa-
tion of TRPA1 over physiologically relevant temperature
range, we analysed MO-evoked currents at various tem-
peratures using the whole-cell voltage clamp technique.
In order to better quantify the activity of recombinant
TRPA1, we generated human embryonic kidney (HEK)
293 cell lines stably expressing either rat or human
TRPA1. Unless otherwise indicated, data presented in
the Results were obtained from cells stably expressing
TRPA1.
Under our recording conditions, application of MO at
23°C induced robust activation followed by rapid
attenuation of current amplitude even during the pre-
sence of MO. The acute desensitization accompanied
strong tachyphylaxis such that repeated application of
MO following initial activation did not evoke current
any longer (Figure 1A). These activation and desensitiza-
tion of TRPA1 are consistent with the properties
reported by other groups [25-27]. To evaluate the effects
of warm temperature on the MO-evoked activation of
TRPA1, we increased bath temperature to 34°C or 39°C
upon the application of MO. Surprisingly, the ampli-
tudes of MO-evoked currents were markedly reduced at
warm temperatures (Figure 1B-C). The current-voltage
relationship demonstrated that warmth-induced
suppression of MO-evoked currents was not dependent
on membrane potential (Figure 1D). Suppression of
MO-induced activation of TRPA1 was steeply regulated
around the skin surface temperature, which is approxi-
mately 31°C (Figure 1E). A slight decrease or increase in
temperature resulted in an increase or decrease, respec-
tively, in the amplitude of MO-evoked currents.
Warmth-induced suppression was almost complete at a
temperature of 39°C, which is well below the level
which evokes heat nociception in humans [28]. The
application of MO at warm temperature not only
reduced the initial activation but also induced strong
tachyphylaxis. A second application of MO at 23°C fol-
lowing the first application of MO at 39°C did not
evoke any currents either (Figure 1C). Heat-induced
suppression was observed not only in a particular cell
line stably transfected with rat TRPA1, but also
occurred in HEK293 cells stably transfected by human
TRPA1 or transiently transfected with human, rat and
mouse TRPA1 (not shown). The warmth-induced sup-
pression was as efficacious as HC030031, a specific inhi-
bitor of TRPA1 [29], which induced 83 ± 6% inhibition
at 10 μM compared with vehicle (n = 7). In contrast to
the effects of warming, inhibition by HC030031 was
rapidly reversed upon washing out of drugs, resulting in
Figure 1 Effects of warming on the activation of TRPA1 by
mustard oil (MO) in HEK293 cells stably expressing rat TRPA1.
A-C (upper), current amplitudes measured at -80 mV by whole-cell
voltage clamp recording in response to MO (100 μM) at 23 (A), 34
(B) and 39°C (C); (bottom), changes in temperature throughout the
recording. I, current density; T, temperature. D, representative
current-voltage relationships of MO-evoked currents at the
temperature indicated. V, membrane potential. E, temperature-
response relationship of MO-evoked currents at various
temperatures. Rel. Curr., relative current density normalized to the
average current density at 23°C n = 10 in each bar. F, representative
current traces evoked by 100 μM MO with pretreatment and
coapplication of vehicle (Veh, black) or HC030031 (10 μM, HC, red)
during the period indicated by a white bar. The arrow indicates an
increase in current following washout of drugs. Dotted lines
indicate the duration of MO application. Scale bar, 0.1 nA, 1 min.
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1F). These results suggest that innocuous warm tem-
peratures can efficaciously suppress the agonist activa-
tion of TRPA1, and that warmth-induced suppression is
not simply a result of the prevention or attenuation of
activation, but may involve more complicated mechan-
isms, including desensitization of TRPA1.
Warmth-induced suppression was not unique to MO,
b u ta l s oo c c u r r e dw h e na n o t h er agonist, formaldehyde,
activated TRPA1 (Figure 2A and 2B). The effects cannot
be attributed to warmth-specific impairment of covalent
modification by electrophilic agonists, because heat-
induced suppression also occurred when non-electrophi-
l i ca g o n i s t ss u c ha sf l u f e n a m i ca c i d( F F A )[ 3 0 ]o r
menthol [9] were used (Figure 2A and 2B). Importantly,
pre-emptive warming (39°C, 2 min) without co-applica-
tion of MO neither evoked any current nor decreased
the activation of TRPA1 when followed by application
of MO (100 μM) at 23°C (Figure 2C; -362 ± 50 pA/pF
in control vs -337 ± 71 pA/pF in the heated group, n =
11, P > 0.7), suggesting that warmth does not alter the
functionality of TRPA1 in the resting state.
Warmth decreases apparent affinity and enhances
desensitization of TRPA1
Since cold induces or enhances TRPA1 gating [2,20,31],
it is possible that a counter agonistic heat stimulus
reduces agonist activation. When we compared the
effects of warming following the application of various
concentrations of MO, the suppressive effects became
weaker as the concentration of MO increased (Figure
3A). When we quantified peak amplitudes, EC50
increased by ~2 fold from 122 μM (95% CI: 69-217 μM)
at 23°C to 268 μM (138-522 μM) at 39°C. However,
there was little effect on hill slope (2.1 at 23°C vs 2.5 at
39°C), top plateau (934 pA/pF at 23°C vs 883 pA/pF at
39°C) and bottom plateau (27 pA/pF at 23°C vs 12 pA/
pF at 39°C). In this analysis, it was evident that warmth
accelerated the time courses of current activation and
desensitization as evidenced by the significant reduction
of 20-80% in rise time and decay time constants (τ)a t
39°C (Figure 3C). In particular, τ was greatly affected
and reduced by 4-fold upon warming at 1 mM MO.
Consequently, the mean area under the curve of MO-
evoked currents decreased upon warming by approxi-
mately 3-fold at 1 mM (14.5 ± 0.2 at 23°C vs 5.1 ± 0.6
at 39°C, n =6 ,P < 0.005). These results suggest that
warmth reduced the apparent affinity of TRPA1 for MO
and enhanced the rate of desensitization.
Although warming affects the rate of MO-evoked acti-
vation of TRPA1, warmth-induced enhancement of
desensitization may not entirely result from warmth-
induced acceleration of the time course of activation. In
HEK293 cells transiently transfected with rat TRPA1,
MO-evoked activation was often not uniform but cur-
rents were frequently sustained even following washout
as exemplified in Figure 4A. Such sustained currents
were immediately suppressed by increasing temperature
(Figure 4A). To assess the effects of warmth on the rate
of desensitization independen to ft h er a t eo fa c t i v a t i o n ,
we compared the rate of current decay when the cells
were exposed to either 23 or 39°C following the activa-
tion by MO at 23°C. For better quantification, we used
the HEK293 cells stably expressing rat TRPA1. When
MO application was followed by warming to 39°C, the
decay of the currents occurred immediately, with a sig-
nificantly faster time course than that at 23°C (Figure
4B-D). Second application of MO at 23°C did not evoke
any currents in both groups (not shown). Such warmth-
induced decay was not dependent upon external Ca
2+
since warmth-induced suppression of TRPA1 occurred
Figure 2 Warming reduces agonist-induced activity of TRPA1.
A, example traces of currents evoked by formaldehyde (FA, 0.01%),
menthol (MN, 250 μM), flufenamic acid (FFA, 300 μM) at 23°C (black)
or 39°C (red). Superimposed traces were obtained from
independent cells. Scale bar, 0.1 nA/pF, 30 s. B, normalized TRPA1
current densities at 23°C (white) and 39°C (black) induced by various
agonists. *P < 0.05; **P < 0.001, n = 4-6 in each group. C, sample
traces of currents evoked by 100 μM MO (black bars) with or
without pre-emptive heating as indicated. Scale bar, 0.2 nA/pF, 2
min. All data in panel A to C were obtained in rat TRPA1 except
data for MN and FA in panel A and B that were obtained from
human TRPA1.
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2+ instead of
external Ca
2+ (Figure 4D). Furthermore, even when the
Ca
2+ level was strongly buffered by intracellular BAPTA,
warmth -induced suppression of TRPA1 also occurred
(not shown).
To further test the notion that warmth enhances
desensitization of TRPA1, we tested whether heat
facilitated tachyphylaxis. To attenuate tachyphylaxis of
TRPA1 upon repeated agonist application, we used a
divalent cation-free recording solution. To suppress
endogenous background currents under these condi-
tions, NMDG was used as a major charge carrier in
the external solution. Like TRPV1 [32], TRPA1 shows
permeation with NMDG [33]. Under these conditions,
TRPA1 can be activated by repeated application of
FFA with only a slight tachyphylaxis (Figure 5A and
5C). To test whether warmth enhances tachyphylaxis,
we applied heat following the achievement of the
apparent peak during the first application of FFA at
23°C (Figure 5B). Warming strongly suppressed the
amplitude of FFA-induced currents by 95%. The sec-
ond application of FFA at 23°C in this group evoked
only small amplitude currents, which were significantly
smaller than that in the non-heated group (Figure 5C).
Of note, under this recording condition, warming dur-
ing FFA application induced suppression preceded by
transient potentiation of currents (arrowhead in Figure
5B), which was not obvious when Na
+ was used as a
major charge carrier (Figure 4A and 4B). Overall, these
results strongly support the idea that warmth-induced
suppression of TRPA1 accompanies enhancement of
desensitization.
Figure 4 Effects of warming on acute desensitization of TRPA1.
A, an example of the effects of heat following two consecutive
application of MO (30 μM) in a HEK293 cell transiently transfected
by rat TRPA1. Scale bar, 3 min, 1 nA. B, representative current traces
demonstrating the effects of temperatures on desensitization of rat
TRPA1 following MO-evoked activation at 23°C. Currents were
obtained from HEK293 cells stably expressing rat TRPA1. Washout of
MO was performed at 23°C (left) or 39°C (right). The changes in
temperature during recordings are shown in lower panels. Vertical
dotted lines represent equivalent duration of time following
washout of MO in different temperature as indicated. C, Examples of
relative current traces recorded during the period between dotted
lines in panel B obtained from multiple cells. The arrow indicates
the time point at which the exposure to different temperatures was
initiated. D, decay τ measured from the experiments in panel B in
the presence of extracellular Ca
2+ or Ba
2+ at 23 (white) or 39°C
(black). *, P < 0.05; **, P < 0.005 in Student’s t test; n = 4-6.
Figure 3 Effects of warming on the apparent affinity of TRPA1
to MO and time course for activation and desensitization. A,
superimposed whole-cell current traces at -80 mV recorded from
HEK293 cells stably expressing rat TRPA1 at 23°C (black) or 39°C
(red) in response to 0.1, 0.3 and 1 mM MO. Superimposed traces
were obtained from independent cells. Scale bars, 30 s, 0.1 (left), 0.3
(middle) and 0.5 nA/pF (right). B, concentration-dependent
relationship of MO-evoked currents at 23°C (white) and 39°C (black).
C, 20-80% rise time (left) and decay time constant (τ) (right) of
currents evoked by 0.3 or 1 mM MO at 23°C (white) and 39°C
(black). P < 0.05 in two-way ANOVA; *P < 0.05 in Bonferroni post-
hoc test; n = 4-6.
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MO-induced activation of the mutant TRPA1 N855S
that underlies familial episodic pain syndrome [6]. Like
wild-type TRPA1, the amplitude of currents evoked by
100 μM MO in HEK293 cells transiently transfected
with TRPA1 N855S was significantly reduced by
approximately 70% at 33°C compared with the ampli-
tude at 23°C (-262 ± 61 pA/pF and -847 ± 142 pA/pF,
respectively, P < 0.05).
We tested whether warmth-induced suppression and
desensitization also occurred in another cold-gated
channel, TRPM8. In HEK 293 cells transiently trans-
fected with TRPM8, menthol-evoked currents were
almost completely suppressed when menthol was super-
imposed by a heat stimulus at 40°C. However, unlike
TRPA1, the amplitudes of menthol-evoked currents
were reversed approximately to the pre-heating level
upon returning to room temperature (Figure 6). These
results suggest that warmth may commonly suppress
the agonist activation of TRPM8 and TRPA1, but only
enhance desensitization of TRPA1 and not TRPM8.
Innocuous warm temperature suppressed MO-induced
ionic currents in sensory neurons
Next, we determined whether warmth-induced suppres-
sion also occurred in native TRPA1 by recording MO-
evoked currents in cultured rat trigeminal ganglia (TG)
neurons. Warming to 39°C without MO only modestly
changed the baseline current (4 ± 0.7 pA/pF, n = 16).
MO (300 μM) at 23°C evoked currents in 18 out of 23
neurons. When MO was applied at 39°C, however, only
11 out of 26 neurons responded (P < 0.05 in Fisher’s
exact test). The amplitude of the MO-evoked current
was significantly attenuated in the 39°C group compared
with the 23°C group (Figure 7A-C). As with recombi-
nant TRPA1, however, pre-emptive warming did not
affect the activation of TRPA1 by MO. Neuronal
responses by the application of MO (10, 30, and 100
μM) at 23°C was not significantly different between two
groups of neurons with or without pre-exposure to
warming at 39°C for 2 min (Figure 7D).
Figure 5 Effects of warming on tachyphylaxis of TRPA1. A-B,
representative current traces evoked by two consecutive
applications of FFA (300 μM) in two independent HEK293 cells
stably expressing human TRPA1. Initially FFA was applied at 23°C for
30 s. During the later half of the first application, FFA was applied at
either 23°C (A) or 39°C (B). The second application was performed
at 23°C in both groups. The letters a to d indicate time points for
the quantification shown in panel C. The arrowhead indicates
transient potentiation of TRPA1 currents by heat under this
recording condition. Scale bar, 30 s, 4 nA (left), 2 nA (right). C,
averaged relative current responses measured at points a to d in
panel A and B. Current amplitudes were normalized to the
respective peak amplitude during the initial half of the first
application of FFA at 23°C. Black and white bars represent groups
with or without heat co-application, respectively, during the first
FFA application. **P < 0.001 in Student’s t test; n =5 .
Figure 6 Effects of warming on cold- and menthol-gated
channel TRPM8. A, representative current traces induced by
menthol (300 μM, black bar) from a HEK293 cell transiently
transfected with rat TRPM8. Letters a to d represent the time points
for quantification shown in panel B. Ca
2+ in the external solution
was replaced with Ba
2+. Scale bar, 0.5 nA/pF, 30 s; Vm = ± 80 mV. B,
averaged current density at the indicated voltages. *P < 0.05 in
Mann-Whitney rank-sum test; n =4 .
Figure 7 Effects of warming on MO-induced ionic currents and
intracellular Ca
2+ level in rat trigeminal ganglia (TG) neurons. A
(bottom), representative traces evoked by warming (left), MO (300
μM) at 23°C (middle) or at 39°C (right) in cultured TG neurons;
(upper), temperature during the equivalent periods. Vm = -70 mV.
Scale bar, 0.5 nA, 1 min. B, data derived from experiments in panel
A. Dotted lines represent the threshold determining responsiveness
of each group. C, box-and-whisker plot comparing MO-evoked
current densities at 23°C and 39°C. Only responders in panel B were
quantified. Error bars, 5th to 95th percentile; *P < 0.05 in Mann-
Whitney U test; n = 18 at 23°C and n = 11 at 39°C. D, changes in
Fura ratio evoked by MO applied at 23°C with (black bars) or
without (white bars) pre-emptive heat (39°C, 2 min). P > 0.14 in
two-way ANOVA; 77-145 neurons/group.
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The major finding of this study is that agonist-induced
activation of TRPA1 is strongly inhibited by innocuous
warmth. Such inhibition is mediated by suppression, an
attenuated activation, as well as desensitization, an
inability of activation following initial activation. Our
results suggest that heat reduces the functionality of
TRPA1 only after activation by agonists. Pre-emptive
heating without co-application of chemical agonists did
not affect functionality of recombinant or native
TRPA1, indicating that warmth by itself does not non-
specifically impair the function of TRPA1. Heat-induced
suppression of TRPA1 is apparently not the result of
impaired covalent modification. Indeed, the rate con-
stant representing the nucleophilic reaction between
cysteine and hydrogen peroxide increases as tempera-
ture increases [34].
One plausible mechanism of heat-induced suppression
of TRPA1 is that heat may act as a ‘negative’ modulator
of TRPA1. In this model, agonistic temperatures posi-
tively modulate, whereas counter thermal stimuli may
negatively modulate thermosensitive TRP channels.
Indeed, agonist activation of heat-gated TRPV1 is
strongly suppressed by cold, the counter agonistic tem-
perature [35]. Although the time course of activation by
MO was accelerated by heating, the EC50 increased at
warm temperatures. In contrast, the heat-gated channel
TRPV1 shows decreased EC50 upon heating [36]. Since
TRPA1 can be gated and potentiated by cold [20], heat
may act as a negative and positive modulator of TRPA1
and TRPV1, respectively. Recently, it was demonstrated
that capsaicin- and heat-evoked activation may occur
through distinct structural entities, and TRPV1, with
simultaneous N628K/N652T/Y653T mutations, showed
impaired activation by heat with intact activation by
capsaicin [37]. Interestingly, this mutant TRPV1 also
showed impairment in heat-induced potentiation and
diminished cold-induced suppression of capsaicin-
evoked currents [38], suggesting that the impairment of
the heat activation pathway also attenuates cold-induced
suppression. Therefore, it is also possible that the
decreased EC50 of TRPA1 by warmth may be, at least in
part, a result of negative modulation involving the cold
activation mechanism of TRPA1.
Another interesting finding was that heat enhanced
desensitization and tachyphylaxis of TRPA1 following
agonist activation, but not that of TRPM8. The effects
of heat on desensitization of TRPA1 cannot be fully
explained by the accelerated activation time course. It is
not clear how heat induces desensitization of MO-
evoked currents, and the mechanisms need to be further
investigated in the future. Importantly, heat-induced
desensitization of TRPA1 is not the consequence of
thermal activation of TRPA1. Although the structural
basis of cold-induced activation/potentiation and heat-
induced suppression/desensitization of TRPA1 is com-
pletely unknown, we speculate that thermal activation
and desensitization may represent independent pro-
cesses. Related to this notion is the finding that the
TRPA1 orthologue from insects (drosophila and mos-
quito) and snake are activated by heat [39-41]. Droso-
phila TRPA1 is not only activated by heat but is also
desensitized when it is expressed in HEK293 cells (M.K.
Chung, unpublished observation). This is consistent
with heat-induced activation and desensitization of
another insect TRPA1 orthologue, a honeybee Hyme-
noptera-specific TRPA [42]. The heat-desensitizing
mechanism of drosophila and mammalian TRPA1 may
be evolutionarily conserved, while thermal activating
mechanisms are not. Further structure-function studies
are required to investigate the distinct region involved
in thermal activation and heat desensitization of these
channels. Alternatively, it is possible that the agonist-
induced desensitization process is highly sensitive to ele-
vated temperature and heat enhances the rate of desen-
sitization induced by agonist. Investigation of the
detailed mechanisms of TRPA1 desensitization and their
temperature sensitivity may provide further mechanistic
insights.
Since desensitization of TRPA1 is related with the
internalization of channel proteins [43], we cannot
exclude the possibility that internalization of TRPA1 by
warming could contribute the warmth-induced inhibi-
tion of TRPA1 activity. However, we think that the
warmth-induced inhibition of TRPA1 cannot be mainly
due to such mechanism based upon two reasons: 1)
Current amplitudes evoked by 1 mM MO were compar-
able between 23 and 39°C, suggesting the equivalent
existence of functional TRPA1 at the surface of plasma
membrane, and 2) the decay time constant of inhibition
was as small as < 5 sec, which may be too fast for the
internalization of the entire channels in the plasma
membrane. Further biochemical and cell biological
approaches are required to clarify the mechanisms of
warmth-induced effects on TRPA1.
Mild heating not only suppressed recombinant
TRPA1, but also attenuated MO-evoked ionic currents
in TG neurons, suggesting that warmth suppresses the
activation of endogenous TRPA1. We cannot exclude a
possibility that MO-induced responses partly involve
other molecules, e.g., TRPV1 [44]. Indeed, we also
observed a weak activation of TRPV1 by a high concen-
tration of MO and superimposition of MO on warmth
potentiated currents (M.K. Chung, unpublished observa-
tion). Therefore, MO-evoked currents at warm tempera-
t u r ei ns e n s o r yn e u r o n sc o u l db ep a r t l yt h er e s u l to f
Wang et al. Molecular Pain 2012, 8:22
http://www.molecularpain.com/content/8/1/22
Page 6 of 9activation of TRPV1. However, such agonistic effects of
MO on TRPV1 cannot explain heat-induced suppression
of MO-evoked currents in TG, which strongly suggest
substantial suppression of agonist-induced activation of
TRPA1 in nociceptors.
Persistent activation of TRPA1 may contribute to the
maintenance of persistent pain at the site of injury or
inflammation [14,16]. We demonstrated that innocuous
heating suppressed MO-induced nociceptor activation.
Tissue temperature has been found to increase by
approximately 3 - 4°C at the site of acute inflammation
in experimental animals [22,23], which may substantially
attenuate activation of TRPA1 by putative endogenous
agonists. Therefore, local hyperthermia during acute
inflammation may be an endogenous anti-nociceptive
mechanism preventing excessive pain at the site of
injury. Also heating of local tissues or the whole body is
a remedy that has been widely used for attenuating
chronic pain conditions, such as low back pain and
osteoarthritis [45-47]. Our results suggest that heat-
induced suppression of TRPA1 may provide, in part, a
peripheral molecular mechanism of heat therapy. It is
worthwhile to note that warmth desensitizes TRPA1
only when the channel is activated, but not in the rest-
ing state (Figures 2C and 7D). Thus innocuous heating
may preferentially desensitize TRPA1 in an active but
not a resting state, thus preserving the role of TRPA1 as
a sensor of tissue damage.
In conclusion, we demonstrated that TRPA1 is mod-
estly activated and potentiated by cold, but is strongly
suppressed by innocuous heat. Warmth-induced sup-
pression is a result, not only of reduced activation, but
also of enhanced desensitization. These results may pro-
vide a novel insight for thermosensitivity of TRPA1 and
a mechanistic rationale for the application of mild heat-
ing to attenuate nociception.
Methods
Cell culture and transfection of cDNA
Rat TRPA1, human TRPA1, rat TRPM8 cDNAs were
generously gifted by Dr. David Julius (University of Cali-
fornia, San Francisco, CA). Mouse TRPA1 cDNA was
kindly gifted by Dr. Ardem Patapoutian (Scripps
Research Institute, San Diego, CA). To generate the
human TRPA1 N855S mutant, site directed mutagenesis
was performed by overlap extension polymerase chain
reaction methods using a pair of specific primers.
HEK293 cells were maintained as previously described
[38]. Cells were maintained in Dulbecco’s Modified
Eagle Medium (DMEM) containing 10% fetal bovine
serum and penicillin/streptomycin/glutamine (PSG) in
5% CO2 at 37°C. Lipofectamine-2000 (Invitrogen) was
used for the transient transfection of cDNA. To identify
transfected cells, cDNA encoding mCherry was co-
transfected. HEK293 cells stably transfected with rat or
human TRPA1 were generated by selection of trans-
fected cells with G418. Resistant clones were screened
for functional expression of TRPA1 by electrophysiology
and constitutive expression of mRNA of TRPA1. Trans-
fected HEK293 cells were plated onto polyornithine-
coated round coverslips (8-mm in diameter) and used
for experiments after 16 to 24 hours.
Culture of TG neurons
Rat TG neurons were dissected as described previously
[38]. All procedures were conducted using twelve male
Sprague-Dawley rats (body weight 200-300 g, Harlan) in
accordance with the NIH Guide for the Care and Use of
Laboratory Animals and under a University of Mary-
land-approved Institutional Animal Care and Use Com-
mittee protocol. Rats were euthanized using a lethal
dose of sodium pentobarbital. The ganglia were dis-
sected out and minced in cold DMEM/F12 containing
10% horse serum and PSG. TG were incubated in 1 mg/
ml collagenase (type XI, Sigma) for 30 min at 37°C and
triturated with flame-polished Pasteur pipettes. The
ganglia were incubated in phosphate-buffered saline
(PBS) containing 0.05% trypsin and 0.1% EDTA for 2
min at 37°C. After washing with serum-containing cul-
ture medium, dissociated cells were added to a 25% Per-
coll gradient, centrifuged for 12 min at 900 g, and
plated on to polyornithine- and laminin-coated glass
coverslips. The neurons were cultured in DMEM con-
taining 10% horse serum, 1% PSG, and 100 ng/ml nerve
growth factor, in 5% CO2 at 37°C. The neurons were
assayed 16-48 h later.
Electrophysiology
Following previously described methods [32,38], conven-
tional whole-cell patch clamp recordings were per-
formed using the Axopatch 200B with Digidata 1440
interface (Molecular Devices). Unless otherwise indi-
cated, the bath solution contained 140 NaCl, 5 KCl, 2
CaCl2,1M g C l 2, 10 glucose, 10 HEPES (in mM, pH 7.4
adjusted with NaOH, 300-310 mOsm). The pipette solu-
tion contained 140 KCl, 5 NaCl, 10 EGTA, 1 CaCl2,1
MgCl2, 2.5 Mg-ATP (in mM, pH 7.3 adjusted with
KOH, 290-300 mOsm). As indicated in the Results sec-
tion, external Ca
2+ was replaced with Ba
2+ in some
experiments. To reduce tachyphylaxis of TRPA1 activa-
tion in Figure 5, we used divalent-free internal and
external solutions containing 150 X-OH, 10 HEPES, 10
EDTA (X = Na in the internal and N-methyl-d-gluca-
mine (NMDG) in the external solution; pH 7.4 adjusted
with HCl, 290-300 mOsm). Osmolarity of every solution
was measured using a vapour pressure osmometer
(Wescor) and adjusted using mannitol as necessary. Bor-
osilicate glass electrodes with tip resistances of 2-4 MΩ
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resistance was compensated > 75%. A 3 M KCl agar salt
bridge was used throughout the experiments. To evalu-
ate current amplitudes and current-voltage relationships
at the same time in HEK293 cells, we applied repetitive
200 ms voltage ramp pulses (-100 to +100 mV, 1 mV/
ms at 0.5 Hz) from a holding potential of 0 mV. Voltage
protocols were delivered and currents were acquired
using Clampex (Molecular devices).
In sensory neurons, membrane potential was continu-
ously clamped at -70 mV. Following the application of
MO, neurons showing currents greater than -4 pA/pF,
which was twice the mean rms noise, were regarded as
responders. In groups exposed to 39°C heat, the thresh-
old was determined as -8 pA/pF, which was twice the
mean heat-induced change.
Bath temperature was controlled using an in-line hea-
ter (Warner instruments) connected to a valve-con-
trolled perfusion system driven by gravity. Actual bath
temperature was monitored continuously with a ther-
mocouple (IT-18, Physitemp) placed within 4 mm of the
patch-clamped cell and recorded in Clampex throughout
the experiment. The bath (< 200 μl) was continuously
perfused at a rate of ~3 ml/min. Temperature values
referred to in the results section represent the mean of
the actual temperatures measured for each group. In
this study, we used the term ‘warmth’ to indicate an
innocuous range of heat above that of the skin surface
temperature, i.e., approximately 32°C to 40°C.
Ratiometric Ca
2+ imaging
Ratiometric Ca
2+ imaging experiments and analysis were
performed as described previously [48] with slight modi-
fications. Sensory neurons were loaded with 1 μMf u r a -
2 acetoxymethyl ester (Anaspec, Inc) with 0.01% pluro-
nic acid (Anaspec, Inc) for 40 min at 37°C in Ca
2+ ima-
ging buffer containing 130 NaCl, 3 KCl, 2.5 CaCl2,0 . 6
MgCl2, 10 HEPES, 10 sucrose, 1.2 NaHCO3 (in mM, pH
7.45, 310 mOsm after adjustment with mannitol). Mea-
surement of fluorescence was performed using an
inverted fluorescence microscope (Nikon) equipped with
a filter changer (Sutter Instruments) and a CCD camera
(Nikon). Paired images (340 nm and 380 nm excitation,
510 nm emission) were collected every 2 s and the fura
ratios (emission at 340 nm excitation/emission at 380
nm excitation) were calculated. Data acquisition and
analysis were performed using NIS Elements (Nikon).
Reagents
MO (allylisothiocyanate, Sigma) was diluted in DMSO
for cellular electrophysiological experiments. Stocks of
HC030031, menthol and flufenamic acid (Sigma) were
dissolved in DMSO and diluted in the external solution.
Formaldehyde (37%, Fisher) was diluted directly in the
external solution.
Data analysis and statistics
To minimize variability due to the differences in indivi-
dual cell size, we determined current densities (current
amplitude/membrane capacitance). Statistical analysis
was performed using Prism or SigmaStat. Curve fitting
of current traces was performed using pClamp (Molecu-
lar Devices). Concentration-dependent relationships
were fitted by a logistics function: Y = Min +( Max-
Min)/(1 + 10^(LogEC50 - X)×H)w h e r eY =c u r r e n t
density, Min and Max = Minimum and maximum pla-
teaus, EC50 = half-maximal concentration, X = log of
concentration, H = Hill slope. The curves were fitted
without constraining the four parameters. Data in all fig-
ures represent mean ± s.e.m. Unless otherwise indicated,
the Student’s t test was used to compare two groups and
P < 0.05 was considered to be statistically significant.
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